Sumitomo and Tosoh to Dissolve Polyethylene Joint Venture

Sumitomo Chemical Co., Ltd. (“Sumitomo”) and Tosoh Corporation (“Tosoh”) today announced an agreement to re-organize collaboration on linear low-density polyethylene (LLDPE) production through their joint venture, Chiba Polyethylene Co., Ltd. The terms of the agreement are as follows:

  • Effective the end of December 2004, Tosoh will transfer to Sumitomo its equity ownership (25%, 125 million yen) in Chiba Polyethylene Co., Ltd., which will then become a wholly owned subsidiary of Sumitomo. Concurrently, Sumitomo will acquire Tosoh’s product off-take rights from the joint venture, corresponding to its equity shareholding (25% of the annual production capacity of 100 thousand tons)
  • As a transitional arrangement following the transfer of Tosoh’s ownership in the joint venture, Sumitomo will supply LLDPE of Chiba Polyethylene to Tosoh during an agreed period of time

In the future each of Sumitomo and Tosoh will pursue its own business development independently. Sumitomo will fully utilize the Chiba Polyethylene’s gas phase LLDPE production facilities to manufacture its proprietary, new class of polyethylene (EPPE) and further accelerate its market development of this new product.

Tosoh will continue to market LLDPE that it produces at its Yokkaichi Complex. The company will reinforce its strategy to differentiate itself from others in the polyethylene market by expanding a line of specialty polyethylene products including LLDPE, along with low-density polyethylene, ethylene vinyl acetate copolymer and high-density polyethylene, thereby building a firmer base of its polyethylene business.

For more information on polyethylene, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.